LeonaBio (LONA) EPS (Basic) Growth (1y) (2020 - 2026)
LeonaBio (LONA) EPS (Basic) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -16.29% |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 56.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.76% |
| Dec 31, 2025 | 32.54% |
| Sep 30, 2025 | 75.33% |
| Jun 30, 2025 | 71.26% |
| Mar 31, 2025 | 64.06% |
| Dec 31, 2024 | -261.31% |
| Sep 30, 2024 | 16.95% |
| Jun 30, 2024 | 15.74% |
| Mar 31, 2024 | 8.94% |
| Dec 31, 2023 | 12.44% |
| Sep 30, 2023 | -38.49% |
| Jun 30, 2023 | -37.14% |
| Mar 31, 2023 | 5.52% |
| Dec 31, 2022 | -73.65% |
| Sep 30, 2022 | -9.91% |
| Jun 30, 2022 | 1.10% |
| Mar 31, 2022 | -13.65% |
| Dec 31, 2021 | 32.97% |
| Sep 30, 2021 | 81.36% |
| Jun 30, 2021 | -12.47% |